RxSight (NASDAQ:RXST) Raised to Overweight at Wells Fargo & Company
Wells Fargo & Company upgraded shares of RxSight (NASDAQ:RXST – Free Report) from an equal weight rating to an overweight rating in a report released on Monday, MarketBeat.com reports. Wells Fargo & Company currently has $25.00 price target on the stock, up from their previous price target of $17.00. Several other brokerages also recently issued […]
Wells Fargo & Company upgraded shares of RxSight (NASDAQ:RXST – Free Report) from an equal weight rating to an overweight rating in a report released on Monday, MarketBeat.com reports. Wells Fargo & Company currently has $25.00 price target on the stock, up from their previous price target of $17.00. Several other brokerages also recently issued […]
